ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,797Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 1111

$1.65M Total Retail Price of All Prescriptions

Rank: 9 out of 1111

689 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 689 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 689 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

4% of this provider’s 20,096 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LISINOPRIL 1,067 764 1 2
HYDROCODONE-ACETAMINOPHEN 1,017 629 S3 2 1
FUROSEMIDE 981 821 3 6
SIMVASTATIN 853 692 4 5
LEVOTHYROXINE SODIUM 813 625 5 3
OMEPRAZOLE 793 542 6 4
METOPROLOL TARTRATE 784 599 7 12
POTASSIUM CHLORIDE 692 495 8 9
GABAPENTIN 625 379 9 10
HYDROCHLOROTHIAZIDE 614 433 10 11
TRAMADOL HCL 539 349 11 13
AMLODIPINE BESYLATE 527 452 12 7
METFORMIN HCL 495 331 13 8
CITALOPRAM HBR 464 339 14 14
PRAVASTATIN SODIUM 458 310 15 17
TRAZODONE HCL 419 239 16 32
ZOLPIDEM TARTRATE 409 261 17 16
DONEPEZIL HCL 347 330 18 25
MELOXICAM 333 228 19 18
WARFARIN SODIUM 328 228 20 19
NEXIUM 295 164 21 26
FLUOXETINE HCL 251 145 22 44
PROMETHAZINE HCL 248 121 R 23 69
RANITIDINE HCL 240 201 24 29
NAMENDA 232 219 25 31
GLIPIZIDE 230 175 26 57
CARVEDILOL 203 174 27 21
METOPROLOL SUCCINATE 200 157 28 20
MEGESTROL ACETATE 200 197 R 28 103
OXYBUTYNIN CHLORIDE 198 139 30 110
LYRICA 194 85 31 62
SULFAMETHOXAZOLE-TRIMETHOPRIM 185 126 32 71
CYMBALTA 178 96 33 40
CLOPIDOGREL 173 149 34 30
SERTRALINE HCL 172 97 35 24
AMITRIPTYLINE HCL 170 82 R 36 64
DIGOXIN 170 142 36 47
CYCLOBENZAPRINE HCL 166 68 R 38 37
ATORVASTATIN CALCIUM 166 128 38 15
TAMSULOSIN HCL 165 106 40 28
ATENOLOL 163 102 41 22
PAROXETINE HCL 159 133 42 55
LANTUS 155 112 43 46
FENOFIBRATE 152 61 44 95
PROAIR HFA 146 91 45 38
SPIRIVA 142 96 46 53
PLAVIX 139 121 47 49
KLOR-CON M10 135 131 48 144
DIOVAN 135 113 48 51
DIVALPROEX SODIUM 134 113 50 82
POLYETHYLENE GLYCOL 3350 129 104 51 45
RISPERIDONE 121 62 52 60
MIRTAZAPINE 120 96 53 52
LOVASTATIN 120 62 53 41
CRESTOR 119 83 55 33
GEMFIBROZIL 118 67 56 92
ISOSORBIDE MONONITRATE ER 118 106 56 73
NAPROXEN 115 42 58 85
PHENYTOIN SODIUM EXTENDED 115 46 58 126
CEPHALEXIN 114 71 60 89
GLYBURIDE 114 96 R 60 59
ZETIA 113 70 62 109
NITROSTAT 108 76 63 200
CELEBREX 108 90 63 81
CIPROFLOXACIN HCL 104 80 65 58
QUETIAPINE FUMARATE 103 77 66 76
ADVAIR DISKUS 103 74 66 43
TIZANIDINE HCL 102 32 68 91
PREDNISONE 99 72 69 48
CLONIDINE HCL 98 57 70 42
LEVETIRACETAM 98 62 70 111
SPIRONOLACTONE 97 83 72 83
PRAMIPEXOLE DIHYDROCHLORIDE 96 55 73 186
ENALAPRIL MALEATE 96 53 73 56
SINGULAIR 95 40 75 112
DOXYCYCLINE HYCLATE 94 62 76 113
SYMBICORT 93 48 77 176
ALENDRONATE SODIUM 93 81 77 35
ACTOS 90 47 79 98
PANTOPRAZOLE SODIUM 89 56 80 50
GLIMEPIRIDE 88 73 81 61
LIPITOR 86 59 82 116
AZITHROMYCIN 85 66 83 39
PROPRANOLOL HCL 83 65 84 124
FENTANYL 83 51 S2 84 65
FAMOTIDINE 80 68 86 77
FOSINOPRIL SODIUM 80 52 86 153
LEVOFLOXACIN 80 66 86 88
NOVOLOG 79 57 89 104
LEVEMIR 79 74 89 132
LISINOPRIL-HYDROCHLOROTHIAZIDE 78 58 91 23
MECLIZINE HCL 78 49 91 162
OXYBUTYNIN CHLORIDE ER 77 56 93 114
KLOR-CON M20 76 66 94 79
KLOR-CON 8 75 68 95 120
DICYCLOMINE HCL 74 51 96 225
TERAZOSIN HCL 74 64 96 127
TRIAMTERENE-HCTZ 72 51 98 80
ORPHENADRINE CITRATE 71 12 R 99 335
DOXEPIN HCL 70 46 100 215
IBUPROFEN 69 44 101 66
METOLAZONE 68 48 102 162
ESCITALOPRAM OXALATE 68 58 102 78
DOXAZOSIN MESYLATE 67 66 104 87
LOVAZA 67 46 104 184
METOCLOPRAMIDE HCL 67 20 104 130
PREMARIN 66 35 R 107 90
METHOCARBAMOL 65 29 R 108 159
EXELON 64 64 109 121
EVISTA 64 64 109 148
SUCRALFATE 63 16 111 125
SYNTHROID 63 63 111 63
COMBIVENT 62 28 113 129
DILTIAZEM ER 62 36 113 158
OLANZAPINE 61 36 115 117
LOSARTAN POTASSIUM 59 53 116 34
VENTOLIN HFA 59 27 116 122
HYDROXYZINE PAMOATE 58 30 R 118 205
LAMOTRIGINE 53 30 119 172
MONTELUKAST SODIUM 52 25 120 206
AMIODARONE HCL 51 42 121 145
LACTULOSE 51 41 121 166
NYSTATIN 50 35 123 151
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 3, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.